苏垦农发(601952) - 2025 Q2 - 季度业绩
2025-07-18 08:25
[Key Financial Data and Indicators](index=1&type=section&id=I.%20Key%20Financial%20Data%20and%20Indicators%20for%20the%20First%20Half%20of%202025) The company's H1 2025 performance declined significantly, with total operating revenue down 9.26% and net profit down 27.72% Key Financial Data and Indicators | Item | Current Period (CNY Million) | Prior Period (CNY Million) | Change (%) | | :--- | :--- | :--- | :--- | | **Total Operating Revenue** | 4,588.18 | 5,056.55 | -9.26 | | **Operating Profit** | 232.18 | 328.95 | -29.42 | | **Net Profit Attributable to Parent Company Shareholders** | 213.19 | 294.95 | -27.72 | | **Net Profit Attributable to Parent Company Shareholders (Excluding Non-recurring Items)** | 175.46 | 255.77 | -31.40 | | **Basic Earnings Per Share (CNY)** | 0.15 | 0.21 | -28.57 | | **Total Assets (End of Period, CNY Million)** | 14,634.14 | 14,415.33 (Beginning of Period) | 1.52 | - The company's weighted average return on net assets decreased from **4.40%** in the prior period to **3.08%**, a reduction of **1.32 percentage points**, reflecting a decrease in shareholder returns[3](index=3&type=chunk) [Key Product Production and Sales Volumes](index=2&type=section&id=II.%20Key%20Product%20Production%20and%20Sales%20Operating%20Data) H1 2025 product performance diverged, with strong wheat and barley sales contrasting with declines in processed products Key Product Production and Sales Volumes | Key Product | Production Volume (10,000 Tons) | Sales Volume (10,000 Tons) | Sales Volume YOY Change (%) | | :--- | :--- | :--- | :--- | | Self-produced Wheat and Barley | 63.83 | 18.27 | 77.78% | | Externally Sourced Wheat and Barley | N/A | 20.71 | 124.69% | | Rice Seeds | 8.37 | 8.22 | -19.13% | | Rice | 13.01 | 13.86 | -17.87% | | Edible Oil | 6.57 | 10.70 | -17.53% | - Despite significant increases in wheat and barley sales, production and sales of several core products such as rice seeds, rice, and edible oil experienced **double-digit declines**, indicating structural product risks[5](index=5&type=chunk) - The company's inventory levels for various products, such as rice seeds, rice, and malt, significantly decreased year-on-year by **85.08%**, **43.78%**, and **65.54%** respectively, potentially reflecting the company's destocking strategy or changes in downstream demand[5](index=5&type=chunk) [Explanation of Operating Performance and Financial Condition](index=2&type=section&id=III.%20Explanation%20of%20Operating%20Performance%20and%20Financial%20Condition) H1 performance decline is attributed to unfavorable external market conditions, with low agricultural product prices and declining agricultural material costs compressing margins - The company explicitly stated the main reasons for the performance decline: **low-level fluctuations in agricultural product prices** and a **general downward trend in agricultural material prices**, leading to a **narrowing of gross profit margins** for major products (such as rice and wheat)[6](index=6&type=chunk) Key Financial Indicators Decrease | Indicator | YOY Decrease Amount (CNY Million) | YOY Decrease (%) | | :--- | :--- | :--- | | Consolidated Operating Revenue | 468.00 | 9.26% | | Net Profit Attributable to Parent Company Shareholders | 81.76 | 27.72% | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-recurring Items) | 80.32 | 31.40% | [Risk Warning](index=2&type=section&id=IV.%20Risk%20Warning) This express report contains preliminary, unaudited financial data, which may differ from the final semi-annual report - The data in this performance express report are **preliminary calculations** and have **not been audited** by an accounting firm; the **final data** will be subject to the company's 2025 semi-annual report[1](index=1&type=chunk)[7](index=7&type=chunk) - The company judges that there are **no significant uncertainties** affecting the accuracy of this performance express report[7](index=7&type=chunk)
嘉必优(688089) - 2025 Q2 - 季度业绩预告
2025-07-18 07:50
2025 年 1 月 1 日至 2025 年 6 月 30 日。 (二)业绩预告情况 证券代码:688089 证券简称:嘉必优 公告编号:2025-056 嘉必优生物技术(武汉)股份有限公司 关于 2025 年半年度业绩预增的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 (一)业绩预告期间 经财务部门初步测算: 1、2025 年半年度实现营业收入约 30,670 万元,较上年同期增长 17.59%; 2、2025 年半年度实现归属于母公司所有者的净利润约 10,700 万元,较上年 同期增长 57.61%; 3、2025 年半年度实现归属于母公司所有者的扣除非经常性损益的净利润约 9,300 万元,较上年同期增长 75.45%。 (三)本次业绩预告相关财务数据未经注册会计师审计。 二、上年同期业绩情况和财务状况 1、2024 年半年度营业收入:26,083.24 万元; 2、2024 年半年度利润总额:7,803.82 万元; 四、风险提示 公司本次业绩预告数据未经注册会计师审计,为 ...
国网信通(600131) - 2025 Q2 - 季度业绩
2025-07-17 10:00
[Key Financial Data and Indicators](index=1&type=section&id=Item%20I.%20Key%20Financial%20Data%20and%20Indicators%20for%20the%20First%20Half%20of%202025) H1 2025 saw a 4.55% decline in total operating revenue, while operating profit and total profit increased; however, net profit attributable to shareholders decreased by 10.82% due to higher income tax, with total assets and equity also declining due to accounting adjustments Key Financial Data for H1 2025 (Income Statement) | Item | Current Period (ten thousand yuan) | Prior Period (Restated) (ten thousand yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 352,468.92 | 369,288.95 | -4.55 | | Operating Profit | 32,017.55 | 30,823.17 | 3.87 | | Total Profit | 31,901.63 | 30,581.12 | 4.32 | | Net Profit Attributable to Shareholders of Listed Company | 26,644.08 | 29,878.18 | -10.82 | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-Recurring Gains/Losses) | 20,687.07 | 23,195.55 | -10.81 | | Basic Earnings Per Share (yuan) | 0.22 | 0.25 | -12.00 | Key Financial Data for H1 2025 (Balance Sheet) | Item | End of Current Period (ten thousand yuan) | Beginning of Current Period (Restated) (ten thousand yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,454,353.11 | 1,664,631.33 | -12.63 | | Owners' Equity Attributable to Shareholders of Listed Company | 615,477.53 | 794,745.99 | -22.56 | | Net Assets Per Share Attributable to Shareholders of Listed Company (yuan) | 5.12 | 6.61 | -22.54 | - The company completed the equity acquisition of Yili Technology on June 30, 2025, thus prior period and current period beginning data have been restated to include Yili Technology and its subsidiaries[4](index=4&type=chunk) [Explanation of Operating Performance and Financial Position](index=2&type=section&id=Item%20II.%20Explanation%20of%20Operating%20Performance%20and%20Financial%20Position) The company explained financial data changes, attributing revenue decline to fewer Yili Technology subsidiaries, net profit decrease to higher income tax, asset reduction to receivables collection and acquisition payments, and equity decrease to capital reserve adjustments from common control business combinations - Total operating revenue decreased by **4.55%** year-on-year, primarily due to the reduction in the number of Yili Technology's subsidiaries from four to two on April 1, 2025[5](index=5&type=chunk) - Net profit attributable to shareholders of the listed company decreased by **10.82%** year-on-year, mainly due to increased income tax expenses[5](index=5&type=chunk) - Total assets decreased by **12.63%** from the beginning of the year, primarily due to the collection of accounts receivable and payment for Yili equity acquisition[5](index=5&type=chunk) - Owners' equity attributable to shareholders of the listed company decreased by **22.56%** from the beginning of the year, mainly due to adjustments to capital reserves resulting from a common control business combination during the period[5](index=5&type=chunk) [Risk Warning](index=2&type=section&id=Item%20III.%20Risk%20Warning) The company states that this performance express report contains no significant uncertainties, reminding investors that the data provided are unaudited preliminary figures, with final financial data subject to the official 2025 semi-annual report - The key financial data for the first half of 2025 contained in this announcement are preliminary figures and have not been audited by an accounting firm; the final data will be subject to the company's official 2025 semi-annual report[6](index=6&type=chunk)[7](index=7&type=chunk) [Filed Documents](index=3&type=section&id=Item%20IV.%20Filed%20Documents) The company has filed comparative balance sheets and income statements, signed and sealed by the company's responsible person, chief accountant, and head of accounting department, as required - Comparative balance sheets and income statements, signed and sealed by company management, have been filed[8](index=8&type=chunk)
黔源电力(002039) - 2025 Q2 - 季度业绩
2025-07-17 09:50
[Key Financial Data and Indicators](index=1&type=section&id=%E4%B8%80%E3%80%812025%20%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E6%8C%87%E6%A0%87) Total operating revenue saw a slight increase, while net profit attributable to shareholders decreased by 4.54%, alongside stable total assets and growth in owners' equity Key Financial Data and Indicators for H1 2025 (Unit: RMB) | Item | Current Period | Prior Period | Change (%) | | :--- | :--- | :--- | :--- | | **Total Operating Revenue** | 883,288,624.53 | 872,548,026.36 | 1.23 | | **Operating Profit** | 277,758,541.16 | 262,117,511.67 | 5.97 | | **Total Profit** | 278,152,721.63 | 258,625,689.18 | 7.55 | | **Net Profit Attributable to Shareholders of the Listed Company** | 127,158,591.31 | 133,213,125.43 | -4.54 | | **Basic Earnings Per Share (RMB)** | 0.2974 | 0.3116 | -4.56 | | **Item** | **Current Period End** | **Prior Period End** | **Change (%)** | | **Total Assets** | 15,534,712,638.64 | 15,563,450,198.12 | -0.18 | | **Owners' Equity Attributable to Shareholders of the Listed Company** | 4,019,056,589.08 | 3,910,082,422.29 | 2.79 | [Explanation of Operating Performance and Financial Condition](index=2&type=section&id=%E4%BA%8C%E3%80%81%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5%E6%83%85%E5%86%B5%E8%AF%B4%E6%98%8E) Despite a 23% decrease in water inflow, total power generation slightly increased by 1.55% due to higher initial energy storage, driving revenue and total profit growth, though net profit attributable to shareholders declined by 4.54% due to parent company performance - Despite a **23.00% decrease** in water inflow compared to the prior year, total power generation slightly increased by **1.55%** to **3.201 billion kWh** due to higher initial energy storage, supporting revenue growth[6](index=6&type=chunk) - The **4.54% decrease** in net profit attributable to shareholders was primarily due to a decline in the parent company's net profit, outweighing the profit growth from subsidiary Guizhou Beipanjiang Power Co., Ltd[6](index=6&type=chunk) H1 2025 Power Generation Details by Power Station | Power Station Name | Type | Power Generation (10,000 kWh) | | :--- | :--- | :--- | | Dongqing Hydropower Station | Hydropower | 97,528.99 | | Guangzhao Hydropower Station | Hydropower | 78,699.10 | | Mamaya Hydropower Station | Hydropower | 48,356.37 | | Yinzidu Hydropower Station | Hydropower | 21,045.94 | | Shannipo Hydropower Station | Hydropower | 21,118.50 | | Puding Hydropower Station | Hydropower | 9,321.54 | | Yutang Hydropower Station | Hydropower | 8,529.28 | | Qingxi Hydropower Station | Hydropower | 2,146.46 | | Niudu Hydropower Station | Hydropower | 1,448.01 | | Mamaya Photovoltaic Power Station | Photovoltaic | 10,715.88 | | Guangzhao Photovoltaic Power Station | Photovoltaic | 10,491.78 | | Zhenning Bacao Phase I Photovoltaic Power Station | Photovoltaic | 5,509.00 | | Dongqing Photovoltaic Power Station | Photovoltaic | 5,179.30 | [Other Information](index=2&type=section&id=%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E) The financial data disclosed in this announcement are preliminary and unaudited, with final figures subject to the company's half-yearly report, cautioning investors about investment risks - The financial data in this performance express report are preliminary results from the company's finance department, unaudited by an accounting firm, and may differ from the final half-yearly report[8](index=8&type=chunk) [Documents for Reference](index=2&type=section&id=%E5%9B%9B%E3%80%81%E5%A4%87%E6%9F%A5%E6%96%87%E4%BB%B6) Documents for reference include comparative balance sheets and income statements signed and sealed by the company's senior management - Documents for reference include comparative balance sheets and income statements signed and sealed by the company's legal representative, chief accountant, and head of the accounting department[9](index=9&type=chunk)
杭州银行(600926) - 2025 Q2 - 季度业绩
2025-07-17 09:40
证券代码:600926 证券简称:杭州银行 公告编号:2025-064 优先股代码:360027 优先股简称:杭银优 1 杭州银行股份有限公司 2025年半年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性 和完整性承担法律责任。 本公告所载2025年半年度主要财务数据为初步核算的合并 报表数据,未经会计师事务所审计,具体数据以公司2025年半年 度报告中披露的数据为准,提请投资者注意投资风险。 一、2025年半年度主要财务数据和指标 5、上表基本每股收益、加权平均净资产收益率均未年化计算。 二、经营业绩和财务状况情况说明 2025年上半年,公司坚持以习近平新时代中国特色社会主义 思想为指导,紧紧围绕"从严治行、转型发展"主题主线,积极 做好客户经营,保持了良好的发展态势,为圆满完成全年各项目 标任务、实现"二二五五"战略顺利收官打下了坚实基础。 经营效益持续提升。2025年1-6月,公司实现营业收入200.93 亿元,较上年同期增长3.89%;实现归属于上市公司股东的净利 润116.62亿元,较上年同期增长16.67%。 1 单位: ...
苏美达(600710) - 2025 Q2 - 季度业绩
2025-07-17 09:40
[Key Financial Data and Indicators](index=1&type=section&id=Key%20Financial%20Data%20and%20Indicators) Total operating revenue slightly decreased, but net profit attributable to shareholders increased by **12.62%** to **645.83 million yuan**, demonstrating improved profitability Key Financial Data and Indicators (RMB 10,000) | Item | Current Period (RMB 10,000) | Prior Period (RMB 10,000) | Change (%) | | :--- | :--- | :--- | :--- | | **Total Operating Revenue** | 5,510,144.11 | 5,594,926.15 | -1.52% | | **Operating Profit** | 212,739.44 | 193,669.83 | 9.85% | | **Total Profit** | 217,035.82 | 200,896.22 | 8.03% | | **Net Profit Attributable to Shareholders of Listed Company** | 64,583.03 | 57,348.02 | 12.62% | | **Net Profit Attributable to Shareholders (Excluding Non-Recurring Items)** | 59,555.12 | 49,593.38 | 20.09% | | **Basic Earnings Per Share (Yuan)** | 0.49 | 0.44 | 11.36% | | **Total Assets (Period-End)** | 5,709,325.94 | 5,490,409.39 (Period-Beginning) | 3.99% | | **Total Equity Attributable to Shareholders of Listed Company (Period-End)** | 776,950.22 | 748,433.79 (Period-Beginning) | 3.81% | - The company completed the equity acquisition of Shanghai Jiru Property Co., Ltd. in October 2024, which constituted a business combination under common control, leading to retrospective adjustments of prior period financial data[5](index=5&type=chunk)[6](index=6&type=chunk) [Explanation of Operating Performance and Financial Position](index=2&type=section&id=Explanation%20of%20Operating%20Performance%20and%20Financial%20Position) Robust profit growth in H1 2025, despite slight revenue decrease, was driven by strong overseas business and key segment contributions - The company achieved **55.101 billion yuan** in operating revenue and **645.83 million yuan** in net profit attributable to shareholders in the first half, representing a **12.62%** year-on-year increase[7](index=7&type=chunk) - Leveraging its multi-country overseas industrial chain and supply chain layout, the company actively expanded into overseas emerging markets and the domestic market, achieving **USD 2.93 billion** in exports, a **14%** year-on-year increase[7](index=7&type=chunk) - Total profit from the shipbuilding and shipping business within the advanced manufacturing segment increased by **98%** year-on-year[7](index=7&type=chunk) - The apparel business within the textile and apparel segment, benefiting from overseas production capacity advantages, achieved **USD 440 million** in export shipments in the first half, a **49%** year-on-year increase[7](index=7&type=chunk) [Risk Warning](index=2&type=section&id=Risk%20Warning) The announced 2025 semi-annual financial data are preliminary and unaudited, cautioning investors about potential discrepancies - The financial data contained in this announcement are preliminary and may differ from the final data disclosed in the semi-annual report[8](index=8&type=chunk) [Filed Documents](index=2&type=section&id=Filed%20Documents) Signed and sealed comparative balance sheets and income statements are available for inspection as required - Comparative balance sheets and income statements, signed and sealed by company executives, are available as reference documents[9](index=9&type=chunk)
中微公司(688012) - 2025 Q2 - 季度业绩预告
2025-07-17 08:55
[Performance Forecast Overview](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) The company forecasts significant H1 2025 performance growth, with revenue increasing by approximately **43.88%** to **4.961 billion CNY**, and net profit attributable to shareholders growing **31.61% to 41.28%** to **680-730 million CNY** Key Performance Indicators Forecast for H1 2025 | Indicator | Estimated Amount/Range (CNY) | YoY Growth Rate | | :--- | :--- | :--- | | **Operating Revenue** | Approx. 4.961 billion | Approx. 43.88% | | **Net Profit Attributable to Shareholders** | 680 million - 730 million | 31.61% - 41.28% | | **Non-GAAP Net Profit Attributable to Shareholders** | 510 million - 560 million | 5.54% - 15.89% | H1 2024 Performance Review | Indicator | Amount (CNY) | | :--- | :--- | | **Operating Revenue** | 3.448 billion | | **Net Profit Attributable to Shareholders** | 517 million | | **Non-GAAP Net Profit Attributable to Shareholders** | 483 million | - This performance forecast represents preliminary estimates by the finance department and has not been audited by a certified public accountant[6](index=6&type=chunk) [Analysis of Performance Changes](index=2&type=section&id=III.%20Key%20Reasons%20for%20Performance%20Changes%20in%20Current%20Period) Performance growth is primarily driven by strong core business, especially significant revenue increases from etching and LPCVD thin-film equipment, alongside substantial R&D investment and positive fair value changes [Revenue Growth Drivers](index=2&type=section&id=3.1%20Revenue%20Growth%20Drivers) H1 2025 Revenue Growth by Business Segment | Business Segment | Revenue (CNY) | YoY Growth Rate | | :--- | :--- | :--- | | **Total Operating Revenue** | Approx. 4.961 billion | Approx. 43.88% | | **Etching Equipment** | Approx. 3.781 billion | Approx. 40.12% | | **LPCVD Thin-Film Equipment** | Approx. 199 million | Approx. 608.19% | - Revenue growth is primarily due to a significant increase in shipments of high-end products for advanced logic and memory device manufacturing, achieving large-scale mass production in various critical etching processes[8](index=8&type=chunk) [Profit Change Drivers](index=3&type=section&id=3.2%20Profit%20Change%20Drivers) - A **43.88%** increase in operating revenue led to a gross profit increase of approximately **552 million CNY**, serving as the primary source of profit growth[9](index=9&type=chunk)[10](index=10&type=chunk) - Fair value change gains and investment income from external equity investments totaled approximately **172 million CNY**, an increase of about **180 million CNY** compared to a **8 million CNY** loss in the same period last year, significantly boosting profit[9](index=9&type=chunk) - The growth rate of non-GAAP net profit attributable to shareholders (**5.54%-15.89%**) is significantly lower than that of net profit attributable to shareholders (**31.61%-41.28%**), primarily because a substantial increase in R&D expenses (**+549 million CNY**) eroded part of the operating gross profit growth (**+552 million CNY**)[10](index=10&type=chunk) [R&D Investment and Product Innovation](index=1&type=section&id=3.3%20R%26D%20Investment%20and%20Product%20Innovation) H1 2025 R&D Investment Overview | Indicator | Amount (CNY) | YoY Growth | % of Revenue | | :--- | :--- | :--- | :--- | | **R&D Investment** | Approx. 1.492 billion | Approx. 53.70% | Approx. 30.07% | | **R&D Expenses** | 1.116 billion | Approx. 96.65% | - | - The company's R&D investment as a percentage of revenue (**approx. 30.07%**) is significantly higher than the average of **10%-15%** for STAR Market listed companies[2](index=2&type=chunk)[9](index=9&type=chunk) - The company's R&D projects cover six major categories and over twenty new equipment models, with new product development cycles significantly accelerated from three to five years to two years or less[2](index=2&type=chunk)[8](index=8&type=chunk) [Risk Warning and Other Disclosures](index=3&type=section&id=IV.%20Risk%20Warning) The company states there are no significant uncertainties affecting the accuracy of this performance forecast, reminding investors that disclosed data are preliminary and final financial figures will be based on the official H1 2025 report - The company confirms no significant uncertainties exist that would affect the accuracy of this performance forecast[11](index=11&type=chunk) - The final accurate financial data will be based on the company's officially disclosed H1 2025 semi-annual report, advising investors to be aware of investment risks[12](index=12&type=chunk)
国药现代(600420) - 2025 Q2 - 季度业绩
2025-07-17 08:45
证券代码:600420 证券简称:国药现代 公告编号:2025-057 上海现代制药股份有限公司 2025 年半年度业绩快报 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 本公告所载上海现代制药股份有限公司(以下简称公司)2025 年半年度主 要财务数据为初步核算数据,未经会计师事务所审计,具体数据以公司 2025 年 半年度报告中披露的数据为准,提请投资者注意投资风险。 一、2025年半年度主要财务数据和指标 单位:人民币元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | | 营业总收入 | 4,877,673,521.93 | 5,960,093,922.86 | -18.16 | | 营业利润 | 920,163,725.85 | 1,096,704,023.68 | -16.10 | | 利润总额 | 924,926,954.05 | 1,086,401,902.24 | -14.86 | | 归属于上市公司股东的净利润 | 672,066,877 ...
拓荆科技(688072) - 2025 Q4 - 年度业绩预告
2025-07-17 08:25
证券代码:688072 证券简称:拓荆科技 公告编号:2025-035 拓荆科技股份有限公司 2025 年第二季度业绩预告的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 (一)业绩预告期间 (二)业绩预告情况 1、经财务部门初步测算,预计拓荆科技股份有限公司(以下简称"公司") 2025 年第二季度实现营业收入 121,000 万元至 126,000 万元,同比增长 52%至 58%。 2、经财务部门初步测算,预计公司2025年第二季度实现归属于母公司所有 者的净利润23,800万元至24,700万元,同比增长101%至108%。 2025年4月1日至2025年6月30日。 3、经财务部门初步测算,预计公司2025第二季度实现归属于母公司所有者 的扣除非经常性损益后的净利润21,500万元至22,400万元,同比增长235%至 249%。 4、经财务部门初步测算,预计公司2025年第二季度经营活动产生的现金流 量净额为148,000万元至158,000万元。 二、上年同期业绩情况 ( ...
微芯生物(688321) - 2025 Q2 - 季度业绩预告
2025-07-17 08:15
[Chipscreen Biosciences 2025 Semi-Annual Performance Forecast](index=1&type=section&id=Voluntary%20Disclosure%20Announcement%20by%20Shenzhen%20Chipscreen%20Biosciences%20Co.%2C%20Ltd.%20Regarding%20its%202025%20Semi-Annual%20Performance%20Forecast) The company expects significant growth and a turnaround to profitability in H1 2025, with revenue projected to increase by 35% to approximately RMB 407.29 million, and net profit attributable to shareholders by 173% to approximately RMB 30.06 million [Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) The company anticipates substantial year-on-year growth and a return to profitability for its key financial metrics in the first half of 2025 [Performance Forecast Period](index=1&type=section&id=(I)%20Performance%20Forecast%20Period) This performance forecast covers the period from January 1, 2025, to June 30, 2025 - The statistical period for this performance forecast is from January 1, 2025, to June 30, 2025[2](index=2&type=chunk) [Performance Forecast Details](index=1&type=section&id=(II)%20Performance%20Forecast%20Details) Preliminary calculations indicate significant year-on-year growth across revenue, net profit, and non-recurring net profit, with both profit metrics achieving a turnaround to profitability 2025 Semi-Annual Performance Forecast Key Data | Indicator | 2025 Semi-Annual Estimate | Year-on-Year Growth | | :--- | :--- | :--- | | Operating Revenue | Approx. RMB 407.29 million | 35% | | Net Profit Attributable to Shareholders | Approx. RMB 30.06 million | 173% | | Non-Recurring Net Profit Attributable to Shareholders | Approx. RMB 21.19 million | 145% | [Unaudited Performance Forecast](index=1&type=section&id=(III)%20Unaudited%20Performance%20Forecast) The performance forecast data presented is a preliminary calculation by the company's finance department and has not yet been audited by a certified public accountant - This performance forecast data has not been audited by a certified public accountant[4](index=4&type=chunk) [Prior Period Performance Review](index=1&type=section&id=II.%20Prior%20Period%20Performance%20Review) In H1 2024, the company reported RMB 302.16 million in operating revenue, with net profit and non-recurring net profit both in a loss state, providing a baseline for current period improvements 2024 Semi-Annual Performance Data | Indicator | 2024 Semi-Annual | | :--- | :--- | | Operating Revenue | RMB 302.16 million | | Net Profit Attributable to Shareholders | -RMB 41.01 million | | Non-Recurring Net Profit Attributable to Shareholders | -RMB 47.18 million | [Primary Reasons for Performance Change](index=2&type=section&id=III.%20Primary%20Reasons%20for%20Performance%20Change) The strong performance growth is primarily driven by increased sales of two core products, Chidamide and Seglitaz, with the company achieving profitability in Q2 2025 - Core product sales growth is the main driver of performance improvement - **Chidamide**: New indication for diffuse large B-cell lymphoma included in the national medical insurance catalog - **Seglitaz**: Optimized sales strategy, with its unique "diabetes and liver co-management" advantage gaining market recognition[6](index=6&type=chunk) - Q2 2025 performance was strong, with revenue expected to grow by **43% year-on-year** and **51% quarter-on-quarter**, and net profit attributable to shareholders achieving a turnaround to profitability[6](index=6&type=chunk) [Risk Warning and Other Disclosures](index=2&type=section&id=IV.%20Risk%20Warning%20and%20Other%20Disclosures) The company confirms no significant uncertainties affecting the forecast's accuracy but reminds investors that the data is preliminary and subject to the final semi-annual report - The company states that no significant uncertainties affecting the accuracy of this performance forecast have been identified[7](index=7&type=chunk) - Investors are advised that the current forecast data is preliminary, and the specific financial data will be subject to the company's officially disclosed 2025 semi-annual report[7](index=7&type=chunk)